Editorial
Published on 10 May 2023
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1199354
- 988 views
Type at least 3 characters
1,748 articles
Articles
Editorial
Published on 10 May 2023
Editorial: Measurable residual disease in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1204393
- 1,288 views
Original Research
Published on 10 May 2023
Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1166990
- 1,434 views
Original Research
Published on 09 May 2023
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1161254
- 4,284 views
- 9 citations
Review
Published on 09 May 2023
Liquid biopsies and minimal residual disease in lymphoid malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1173701
- 4,002 views
- 4 citations
Original Research
Published on 09 May 2023
Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1093434
- 1,211 views
Review
Published on 08 May 2023
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1135160
- 5,172 views
- 5 citations
Original Research
Published on 08 May 2023
Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1160966
- 2,689 views
- 1 citation
Case Report
Published on 08 May 2023
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1176173
- 2,581 views
- 2 citations
Original Research
Published on 05 May 2023
Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1183906
- 2,719 views
- 2 citations
Review
Published on 05 May 2023
Liquid biopsies and minimal residual disease in myeloid malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1164017
- 4,469 views
- 1 citation
Original Research
Published on 03 May 2023
Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1186532
- 1,139 views
- 1 citation
Original Research
Published on 03 May 2023
The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1069788
- 1,390 views
- 1 citation
Original Research
Published on 02 May 2023
Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1172910
- 2,561 views
- 3 citations
Original Research
Published on 02 May 2023
CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1150149
- 13,359 views
- 3 citations
Case Report
Published on 01 May 2023
Case Report: Infectious prophylaxis in hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1163175
- 1,662 views
- 2 citations